Healthcare

Blood Plasma Derivatives Market is expected to garner $44,333 million by 2023

"High prevalence of different types of immunodeficiency disorders & hemophilia and upsurge in adoption of plasma derivative-based therapy have driven the growth of the market for blood plasma derivatives in the recent years. Recently, a paradigm shift has been observed in the development of subcutaneous immunoglobulin therapy, as this therapy offers additional advantages for patients, in terms of ease of administration, resulting in their increasing usage. Furthermore, increase in strategic developments by the key players is anticipated to fuel the market growth in the near future."

Press Release

Blood plasma is clear liquid component of blood in which red blood cells, white blood cells, and platelets are suspended. It plays a vital role in maintaining proper pH balance in the body and transporting nutrients throughout the body. It is composed of more than 100 different proteins, including albumin, fibrinogen, immunoglobulins, protease inhibitors, and clotting factors. Plasma derivatives are products that are derived from blood plasma on fractionation, and are widely used to treat variety of diseases. These derivatives include albumin, factor VIII & IX, anti-inhibitor coagulation complex (AICC), immunoglobulins, including Rh immune globulin, alpha 1-proteinase inhibitor concentrate, and anti-thrombin III concentrate.

According to a new report published by Allied Market Research, titled, Blood Plasma Derivatives Market, by Type, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023,” the global blood plasma derivatives market was valued at $23,613 million in 2016, and is projected to reach $44,333 million in 2023, registering a CAGR of 9.3% from 2017 to 2023.

The factors that drive the growth of the blood plasma derivatives market include increase in prevalence of life-threatening diseases such as immunodeficiency diseases and hemophilia, rise in awareness towards blood & plasma donation, upsurge in geriatric population, and growth in adoption of blood plasma derivatives products. However, high cost of plasma derivative-based treatment and risk of side effects associated after using plasma derivatives impede the market growth. Conversely, the development of superior methods for preservation of plasma derivatives along with advanced processes for fractionation and presence of untapped market in emerging economies are expected to provide lucrative growth opportunities for the market.

Download Sample Report @ https://www.alliedmarketresearch.com/request-sample/656

The immunoglobulin segment accounted for the largest share in 2016, owing to high usage & applicability for treating variety of immunodeficiency diseases and improved immunoglobulin production due to the emergence of advanced technologies. However, the albumin segment is expected to grow at the high CAGR from 2017 to 2023.

The utilization rate of plasma derivatives for immunodeficiency diseases is high. However, hemophilia segment is expected to grow at a high CAGR during the forecast period. On the basis of end user, the hospitals segment occupied the largest share in 2016, whereas the clinics segment is expected to provide lucrative market opportunities during the forecast period.

For More Info on this Report, Visit @ https://amazingherald.com/blood-plasma-derivatives-market-expansion-may-cross-44333-million-by-2023-amr/

Key Findings of the Blood Plasma Derivatives Market:

  • The albumin segment accounted for nearly one-sixth share of the global blood plasma derivatives market in 2016.
  • The immunoglobulins segment is expected to grow at highest CAGR from 2017 to 2023.
  • The immunodeficiency diseases segment accounted for around one-third share of the global market in 2016.
  • Europe accounted for around one-third share of the global market in 2016.
  • LAMEA is expected to provide lucrative market growth opportunities from 2017 to 2023.

North America was the leading revenue contributor to the global blood plasma derivatives market in 2016, and is expected to dominate the market during the forecast period. This is attributed to the early approval of plasma derivatives products and large number of fractionation plants in this region. However, Asia-Pacific is expected to grow at the highest CAGR during the study period, due to increase in affordability, surge in healthcare expenditure, and rise in awareness towards plasma derivatives.

 

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Tags

Allied Market Research

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small- & medium-scale enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain. Allied Market Research provides one-stop solution right from data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients understand the significance and impact of market dynamics. The company applies client’s insight on the factors such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligence support to help clients transform into a prominent business firm.

Related Articles

Close